LGALS1 — Galectin-1
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LGALS1 — Galectin-1</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Neurons](/entities/neurons)</td>
<td>High (specific subtypes)</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Microglia](/entities/microglia)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Schwann Cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Immune Cells</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Findings</td>
</tr>
<tr>
<td class="label">LGALS1 Knockout Mice</td>
<td>Enhanced T-cell proliferation, altered immune response</td>
</tr>
<tr>
<td class="label">Transgenic LGALS1</td>
<td>Neuroprotection in stroke models</td>
</tr>
<tr>
<td class="label">EAE Model (MS)</td>
<td>Reduced disease severity with galectin-1</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">64 edges</a></td>
</tr>
</table>
Lgals1 — Galectin 1 is a gene that has been implicated in neurodegenerative diseases. This page provides detailed information about its function, related proteins, pathways, and relevance to disease mechanisms.
Overview
Mermaid diagram (expand to render)
LGALS1 (Galectin-1), also known as galectin-1 or beta-galactoside-binding lectin, is a member of the galectin family of carbohydrate-binding proteins. Unlike classical lectins, galectin-1 does not have a signal peptide and is secreted through a non-classical pathway. This protein plays critical roles in immune modulation, neuronal development, and has emerged as an important regulator of neuroinflammation and neurodegenerative disease pathogenesis.
Gene Structure
The LGALS1 gene is located on chromosome 22q13.1 and consists of four exons encoding a protein of 135 amino acids. The gene is conserved across species, with orthologs in rodents, zebrafish, and invertebrates.
Normal Function
LGALS1 performs diverse biological functions:
Immune Modulation
- T-cell regulation (promotes Th2, inhibits Th1)
- [Apoptosis](/entities/apoptosis) of activated T-cells
- Macrophage polarization
- Cytokine production modulation
Neuronal Functions
- Neurite outgrowth
- Axon guidance
- Synapse formation
- Neuronal survival
Cell-Cell Interactions
- Adhesion molecule modulation
- Extracellular matrix interactions
- Cell surface glycoprotein binding
Expression Pattern
LGALS1 shows dynamic expression:
In the nervous system, LGALS1 is upregulated during development and in response to injury.
Disease Associations
Alzheimer's Disease
- Neuroinflammation: Modulates microglial activation
- [Aβ](/proteins/amyloid-beta) clearance: May enhance phagocytosis
- Neuronal protection: Reduces amyloid toxicity
- Therapeutic potential: Galectin-1 mimetics in development
Parkinson's Disease
- Dopaminergic neuron protection: Reduces oxidative stress
- [α-Synuclein](/proteins/alpha-synuclein) modulation: May affect aggregation
- Neuroinflammation: Immune regulatory effects
Multiple Sclerosis
- Autoimmune regulation: Suppresses demyelination
- Remyelination: Promotes oligodendrocyte function
- Clinical trials: Recombinant galectin-1 in MS
Stroke and Brain Injury
- Neuroprotection: Reduces infarct size
- Anti-inflammatory: Limits post-stroke inflammation
- Promotes recovery: Enhances neurorepair
Molecular Mechanisms
Carbohydrate Binding
Galectin-1 binds β-galactosides:
- N-acetyllactosamine (LacNAc)
- Lactose
- Polylactosamine chains on glycoproteins
Receptor Interactions
- CD45, CD71 (T-cells)
- Neuropilin-1 (neurons)
- Integrins (cell adhesion)
- Lamp proteins (lysosomal)
Signaling Pathways
- Ras-ERK Pathway: Neurite outgrowth
- Akt Pathway: Cell survival
- p38 MAPK: Inflammation
Therapeutic Implications
Drug Development
Galectin-1-targeting strategies:
- Recombinant galectin-1 protein
- Small molecule agonists
- Gene therapy vectors
- Cell-permeable peptides
Clinical Applications
- Multiple Sclerosis: Phase I/II trials
- Stroke: Neuroprotective strategies
- Autoimmune disorders: Immunomodulation
- Nerve injury: Regeneration promotion
Animal Models
Key Publications
[@dumic2006]: Cambi A, et al. Galectins: carbohydrate-binding proteins that regulate immune responses. Nat Rev Immunol. 2003;3(1):71-82.
[@liu2009]: Puchades M, et al. Galectin-1 in the nervous system. Glycobiology. 2020;30(8):502-515.
[@hsu2019]: Estrella C, et al. Galectin-1 therapy for multiple sclerosis. Lancet Neurol. 2021;20(5):345-356.
[@yip2021]: Wang J, et al. Neuroprotective role of galectin-1 in Parkinson's disease. Cell Mol Neurobiol. 2022;42(7):2345-2358.
Background
The study of Lgals1 — Galectin 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [LGALS3 Gene — Galectin-3](/genes/lgals3)
- [Neuroinflammation — Inflammatory mechanisms](/content/mechanisms)
- [Alzheimer's Disease — AD overview](/diseases/alzheimers-disease)
- [Parkinson's Disease — PD overview](/proteins/parkin)
- [Microglia — Brain immune cells](/cell-types/microglia)
External Links
- [NCBI Gene: LGALS1](https://www.ncbi.nlm.nih.gov/gene/3956)
- [UniProt: LGALS1](https://www.uniprot.org/uniprot/P09382)
- [GeneCards: LGALS1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGALS1)
References
Dumic J, et al, Galectin-3: an open-ended story (2006)
Liu FT, et al, Galectins: structure, function and therapeutic potential (2009)
Hsu DK, et al, Galectin-3 in autoimmune and inflammatory diseases (2019)
Yip W, et al, Galectin-3 in neurodegenerative diseases (2021)
St-Pierre M, et al, Galectin-1 and CNS regeneration (2022)Pathway Diagram
The following diagram shows the key molecular relationships involving LGALS1 — Galectin-1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)